Brief: Estia Health Says Foreign Investment Review Board Approval
28/11/2023 08:17
Nov 28 (Reuters) - Estia Health EHE.AX :
* FOREIGN INVESTMENT REVIEW BOARD APPROVAL
* BAIN CAPITAL CONFIRMED TO CO THAT BIDDER HAS RECEIVED
FORMAL
FIRB APPROVAL TO ALLOW IT TO PROCEED WITH TRANSACTION
* FIRB APPROVAL ON PROPOSED ACQUISITION BY FIREBIRD BIDCO TO
ACQUIRE 100% OF ESTIA HEALTH FOR A$3.08 PER SHARE IN CASH
Source text for Eikon: ID:nASX3Dnxr4
Further company coverage: EHE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Estia Health
See all newsBrief: ASX Says Estia Health Will Be Removed From Official List At Close Of Trading On 18 December
Brief: Estia Health Says Intends To Apply For Removal From ASX From Close Of Trading On 18 Dec
Brief: Estia Health Says Scheme Of Arrangement Becomes Legally Effective
Brief: Estia Health Says Supreme Court of NSW Approves Proposed Acquisition By Firebird BidCo
Brief: Estia Health Says Foreign Investment Review Board Approval